glp 1 comorbidities A Balancing Act: Weighing the Benefits of GLP-1s GLP-1a: Going beyond Traditional Use

Future Outlook * GLP-1s may reshape care across obesity, metabolic disease, neurodegeneration, and even oncology and Longevity Medicine

The present review differentiates itself from prior studies through three principal innovations: (1) It provides a critical appraisal of current anti-obesity therapeutic strategies, identifying their pharmacological limitations and clinical shortcomings

Renal effects and natriuresis GLP-1 RAs promote natriuresis, likely through inhibition of the sodium-hydrogen exchanger 3 in the renal proximal tubule

The healthcare system is already stretched thin, with many Medicare beneficiaries facing long waits for appointments with doctors, said Dr

Efficacy and safety of once-weekly semaglutide 20 Mg versus 10 Mg in patients with type 2 diabetes (sustain forte): A double-blind, randomised, phase 3B trial